ArticleArchives of microbiology2026
A recombinant xylose reductase enzyme with biotechnological potential for xylitol production.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Xylitol is a sugar alcohol widely used in the food industry due to its lower caloric value compared to sucrose. Industrial xylitol production relies primarily on chemical hydrogenation processes that require high energy input. Although biotechnological routes represent a more sustainable alternative, their industrial implementation is often limited by enzyme stability and cofactor costs. This study presents the design, expression, and biochemical analysis of recombinant xylose reductase from Neurospora crassa (rNcXR). The optimized gene was cloned into a salt-inducible T7-based expression system and expressed in Escherichia coli (E. coli) BL21-SI. The design incorporated an OmpT signal peptide to encourage secretion into the periplasm, and a 6×His tag at the C-terminus to simplify purification. The recombinant enzyme exhibited a specific activity of 20.87 U/mg, significantly exceeding values previously reported for both native and recombinant xylose reductases. Kinetic characterization revealed that the engineered rNcXR maintains a high substrate affinity while achieving a remarkably enhanced catalytic turnover compared to traditional fungal biocatalysts. Furthermore, experimental validation confirmed an optimized cofactor-binding pocket, supporting the structural enhancements predicted by molecular docking. The rNcXR displayed robust thermodynamic stability at an alkaline pH and maintained high catalytic efficiency at elevated temperatures up to 55 °C. These results demonstrate that the engineered rNcXR represents a resilient and high-performance biocatalyst with strong potential for continuous enzymatic xylitol production in industrial biorefineries.
Indexed as
Identifiers
42423798What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.